Medirom Healthcare Technologies Inc. (MRM) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
MRM currently has 7.9M outstanding shares. with limited dilution risk as only 1.2M additional shares (15.1%) are authorized for issuance. The company has significantly diluted shareholders by 61.16% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 29, 2025 |
20-F filing | 7.9M shares outstanding |
7.9M | 1.2M |
| Aug 23, 2024 |
F-1 filing: F-1 filing for common shares issuable upon the exercise of stock options outstanding as of June 30, 2024 and common shares represented by ADSs issuable upon the exercise of the representative's warrants. |
4.9M | 1.2M |
| Jun 18, 2024 |
20-F filing | 4.9M shares outstanding |
4.9M | 0 |
| May 30, 2023 |
20-F filing | 4.9M shares outstanding |
4.9M | 0 |
| Jan 11, 2023 |
RW filing: The company has decided not to proceed with the proposed public offering and confirms that no securities were sold. |
4.9M | 0 |
| Nov 14, 2022 |
20-F filing | 4.9M shares outstanding |
4.9M | 780K |
| Feb 16, 2022 |
F-1 filing: This F-1 filing is for an offering of ADSs representing common shares, with an option for underwriters to purchase additional ADSs, with the net proceeds intended for working capital and general corporate purposes. |
4.9M | 780K |
| May 17, 2021 |
20-F filing | 4.8M shares outstanding |
4.8M | 0 |
| Nov 20, 2020 |
F-1 filing: This F-1 filing from MEDIROM Healthcare Technologies Inc. details a proposed initial public offering (IPO) of American Depositary Shares (ADSs) on the NASDAQ Capital Market under the symbol 'MRM'. |
N/A | 0 |